Literature DB >> 18339976

Glucose intolerance and diabetes are observed in the long-term follow-up of nonpancreatectomized patients with persistent hyperinsulinemic hypoglycemia of infancy due to mutations in the ABCC8 gene.

Miquel Gussinyer1, María Clemente, Rocio Cebrián, Diego Yeste, Marian Albisu, Antonio Carrascosa.   

Abstract

OBJECTIVE: To report the long-term follow-up of three nonpancreatectomized patients with persistent hyperinsulinemic hypoglycemia of infancy due to mutations in the ABCC8 gene. RESEARCH DESIGN AND METHODS: Oral glucose tolerance test (OGTT) and venous 24-h glucose-insulin profile were performed yearly from adolescence.
RESULTS: Patient 1 (now aged 31 years) developed insulin-dependent diabetes at the age of 25 years. In patient 2 (now aged 17 years), impaired fasting glucose and a diabetic OGTT response with normal A1C values have been observed since the age of 10 years. In patient 3 (now aged 24 years), intolerant OGTT response and hyperglycemic episodes with normal A1C have been observed since the age of 16 years. All patients presented relatively low insulin levels during hyperglycemia, normal BMI, and negative autoantibodies (GAD antibody, insulinoma-associated protein 2, and islet cell antibody).
CONCLUSIONS: Development of glucose metabolism impairment ranging from glucose intolerance to insulin-dependent diabetes is observed in the evolution of these patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18339976     DOI: 10.2337/dc07-2059

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  10 in total

1.  Low genetic confirmation rate in South Indian subjects with a clinical diagnosis of maturity-onset diabetes of the young (MODY) who underwent targeted next-generation sequencing for 13 genes.

Authors:  G Sampathkumar; P P Valiyaparambil; H Kumar; N Bhavani; V Nair; U Menon; A Menon; N Abraham; A Chapla; N Thomas
Journal:  J Endocrinol Invest       Date:  2021-11-06       Impact factor: 4.256

Review 2.  Variable phenotypes of individual and family monogenic cases with hyperinsulinism and diabetes: a systematic review.

Authors:  Kevin Perge; Marc Nicolino
Journal:  Rev Endocr Metab Disord       Date:  2022-08-23       Impact factor: 9.306

Review 3.  Monogenic Diabetes: What It Teaches Us on the Common Forms of Type 1 and Type 2 Diabetes.

Authors:  Yisheng Yang; Lawrence Chan
Journal:  Endocr Rev       Date:  2016-04-01       Impact factor: 19.871

4.  Clinical practice guidelines for congenital hyperinsulinism.

Authors:  Tohru Yorifuji; Reiko Horikawa; Tomonobu Hasegawa; Masanori Adachi; Shun Soneda; Masanori Minagawa; Shinobu Ida; Takeo Yonekura; Yoshiaki Kinoshita; Yutaka Kanamori; Hiroaki Kitagawa; Masato Shinkai; Hideyuki Sasaki; Masaki Nio
Journal:  Clin Pediatr Endocrinol       Date:  2017-07-27

5.  Congenital Hyperinsulinism and Evolution to Sulfonylurearesponsive Diabetes Later in Life due to a Novel Homozygous p.L171F ABCC8 Mutation

Authors:  Emregül Işık; Hüseyin Demirbilek; Jayne A. Houghton; Sian Ellard; Sarah E. Flanagan; Khalid Hussain
Journal:  J Clin Res Pediatr Endocrinol       Date:  2018-03-29

6.  Quantitative Variation in m.3243A > G Mutation Produce Discrete Changes in Energy Metabolism.

Authors:  Ryan P McMillan; Sidney Stewart; James A Budnick; Clayton C Caswell; Matthew W Hulver; Konark Mukherjee; Sarika Srivastava
Journal:  Sci Rep       Date:  2019-04-08       Impact factor: 4.379

7.  Targeted sequencing identifies novel variants in common and rare MODY genes.

Authors:  Lucas S de Santana; Lilian A Caetano; Aline D Costa-Riquetto; Pedro C Franco; Renata P Dotto; André F Reis; Letícia S Weinert; Sandra P Silveiro; Marcio F Vendramini; Flaviene A do Prado; Giovanna C P Abrahão; Ana Gregória F P de Almeida; Maria da G Rodrigues Tavares; Wagner Rodrigo B Gonçalves; Augusto C Santomauro Junior; Bruno Halpern; Alexander A L Jorge; Marcia Nery; Milena G Teles
Journal:  Mol Genet Genomic Med       Date:  2019-10-08       Impact factor: 2.183

8.  Clinical and Genetic Characteristics of ABCC8 Nonneonatal Diabetes Mellitus: A Systematic Review.

Authors:  Meng Li; Xueyao Han; Linong Ji
Journal:  J Diabetes Res       Date:  2021-09-30       Impact factor: 4.011

9.  Nateglinide is Effective for Diabetes Mellitus with Reactive Hypoglycemia in a Child with a Compound Heterozygous ABCC8 Mutation.

Authors:  Akiko Saito-Hakoda; Tohru Yorifuji; Junko Kanno; Shigeo Kure; Ikuma Fujiwara
Journal:  Clin Pediatr Endocrinol       Date:  2012-07-25

10.  ABCC8 R1420H Loss-of-Function Variant in a Southwest American Indian Community: Association With Increased Birth Weight and Doubled Risk of Type 2 Diabetes.

Authors:  Leslie J Baier; Yunhua Li Muller; Maria Sara Remedi; Michael Traurig; Paolo Piaggi; Gregory Wiessner; Ke Huang; Alyssa Stacy; Sayuko Kobes; Jonathan Krakoff; Peter H Bennett; Robert G Nelson; William C Knowler; Robert L Hanson; Colin G Nichols; Clifton Bogardus
Journal:  Diabetes       Date:  2015-08-05       Impact factor: 9.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.